EMORY UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
Not Applicable
Completed
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2005-09-21
- Lead Sponsor
- Emory University
- Target Recruit Count
- 250
- Registration Number
- NCT00208988
- Locations
- 🇺🇸
Grady Memorial Hospital, Atlanta, Georgia, United States
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2012-04-06
- Lead Sponsor
- Emory University
- Target Recruit Count
- 55
- Registration Number
- NCT00208923
- Locations
- 🇺🇸
Emory Universtiy Winship Cancer Institute, Atlanta, Georgia, United States
Phase II Study of Pre-Operative Chemotherapy in Patients With Resectable Local-Regional Carcinoma of Esophagus
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-09-09
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT00208936
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Thyroid Medication and Antidepressants for Treating Major Depression
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-11-17
- Lead Sponsor
- Emory University
- Target Recruit Count
- 153
- Registration Number
- NCT00208702
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Critical Congenital Heart Defect (CHD) Outcomes in Children
Terminated
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-02-13
- Lead Sponsor
- Emory University
- Target Recruit Count
- 150
- Registration Number
- NCT00208689
- Locations
- 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
Effect of Valsartan on Carotid Artery Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2015-12-08
- Lead Sponsor
- Emory University
- Target Recruit Count
- 120
- Registration Number
- NCT00208767
- Locations
- 🇺🇸
Emory University School of Medicine, Atlanta, Georgia, United States
SMART Trial Longitudinal Follow-Up:Off-Pump Versus On-Pump Coronary Artery Bypass Surgery
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Emory University
- Target Recruit Count
- 87
- Registration Number
- NCT00209053
- Locations
- 🇺🇸
Emory Healthcare/EmoryUniversity, Atlanta, Georgia, United States
Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-12-18
- Lead Sponsor
- Emory University
- Target Recruit Count
- 57
- Registration Number
- NCT00208611
- Locations
- 🇺🇸
Emory University, Atlanta, Georgia, United States
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2014-08-12
- Lead Sponsor
- Emory University
- Target Recruit Count
- 32
- Registration Number
- NCT00208962
- Locations
- 🇺🇸
Emory University Winship Cancer Institute, Atlanta, Georgia, United States
Calcium and Vitamin D vs Markers of Adenomatous Polyps
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2013-11-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 92
- Registration Number
- NCT00208793
- Locations
- 🇺🇸
The Emory Clinic, Division of Digestive Diseases, Atlanta, Georgia, United States
© Copyright 2024. All Rights Reserved by MedPath